Join us on December 14 for our Patient-Focused Sessions on Multiple Myeloma, taking place in Charlotte, NC! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Events
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Anal Cancer

Alexandra Guadagno
From today’s top entertainers to racial disparities in access to pain treatment, here’s what is making headlines in the cancer space this week.
Brielle Urciuoli
The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.
 
MIKE HENNESSY, SR.
Research continues to drive the oncology field.
Katie Kosko
A recent study found that socioeconomic status can play a role in survival for patients with anal cancer.
Brielle Urciuoli
Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.
Meeri Kim
More personalized approaches are being developed to treat patients with metastatic disease.
Jason Harris
Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.
 
Jason Harris
The PD-1 inhibitor, Opdivo, may be a promising option for patients with advanced anal cancer, according to a recent study. 
Allie Strickler
From stigma to convenience, there are many reasons why people do not get the HPV vaccine, although it can prevent some types of cancer. Lois Ramondetta, M.D., discusses updated recommendations and hopes for getting more young people vaccinated.
Virginia Powers, PhD
Opdivo may be a promising treatment option for patients with  squamous cell carcinoma of the anal canal. 
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×